What are the Canadian Family Medicine guidelines for diagnosing and managing mumps?

Diagnostic and Management Guidelines for Mumps in Canadian Family Medicine

Diagnose mumps clinically when a patient presents with acute onset of unilateral or bilateral tender, self-limited parotid or salivary gland swelling lasting ≥2 days without other apparent cause, but always pursue laboratory confirmation because one-third of clinically diagnosed cases in Canadian family practice lack serologic evidence of mumps infection. 1

Clinical Diagnosis

Key Diagnostic Criteria

A clinical case requires:

• Acute onset of parotid or other salivary gland swelling
• Tender and self-limited presentation
• Duration ≥2 days
• Unilateral or bilateral involvement
• No other apparent cause identified by the healthcare professional 1

Critical Caveat

Clinical diagnosis alone is unreliable. In a prospective Canadian family practice study, 33% of clinically diagnosed mumps cases had no serologic evidence of recent mumps infection 1. Parotitis has multiple infectious and noninfectious causes, making laboratory confirmation essential for accurate diagnosis.

Laboratory Confirmation

Diagnostic Testing Algorithm

Order buccal swab RT-PCR as your first-line test - it has 90% positivity in confirmed cases compared to only 43% for both IgM ELISA and urine RT-PCR 2.

Laboratory confirmation requires one of:

1. Mumps virus isolation from clinical specimen
2. Significant rise in serum mumps IgG antibody between acute and convalescent titers
3. Positive mumps IgM antibody test 1

Specimen Collection Timing

• Buccal swabs: Collect typically 1 day after symptom onset 2
• Urine samples: Collect typically 2 days after symptom onset 2
• IgM testing: Collect typically 1 day after symptom onset 2

Vaccination History Affects Testing

IgM detection is significantly lower in vaccinated patients (34% positive) compared to unvaccinated patients (64% positive, P=0.02) 2. This means vaccinated patients are more likely to require RT-PCR confirmation rather than relying on serology alone.

Case Classification

Probable Case

• Meets clinical definition AND
• Not epidemiologically linked to confirmed/probable case AND
• Has noncontributory or no serologic/virologic testing 1

Confirmed Case

• Meets laboratory criteria OR
• Meets clinical definition AND is epidemiologically linked to confirmed/probable case 1

Important note: Two probable cases that are epidemiologically linked are considered confirmed even without laboratory confirmation 1.

Management and Public Health Response

Immediate Actions

1. Report immediately to local/provincial health departments - all probable or confirmed cases 1

2. Implement respiratory isolation for 9 days after symptom onset to prevent droplet transmission 1

3. Identify and follow up all contacts, particularly susceptible individuals 1

Vaccination Status Assessment

In recent Canadian outbreaks (2016-2018):

• 35.6% of cases had received ≥2 doses of mumps-containing vaccine 3
• 34% were unvaccinated or partially vaccinated (1 dose) 4
• 39% had unknown vaccination history 4

This demonstrates that even two-dose vaccination does not provide complete protection, with breakthrough infections occurring in fully vaccinated individuals 4.

High-Risk Populations

Target young adults aged 18-34 years - they represent 76-80% of outbreak cases in recent Canadian experience 4, 3. The highest risk group is adults 20-24 years (24.6% of cases) 3.

Outbreak Control Measures

When managing outbreaks:

1. Define the transmission setting (community, school, healthcare facility) 1

2. Identify and vaccinate susceptible persons in the affected population 1

3. Consider exclusion of susceptible unvaccinated persons:

   • Students: Exclude until vaccinated or for 26 days after onset of parotitis in last case 1
   • Healthcare workers: Exclude from day 12 after first exposure through day 26 after last exposure 1
   • Infected individuals: Exclude for 9 days after symptom onset 1

4. Conduct active surveillance for two incubation periods (5-6 weeks) after the last case 1

Communication Strategies

Use social media campaigns for young adult populations - in the Toronto outbreak, social media yielded >500,000 impressions with 1-10% engagement rates, proving effective for this demographic 4.

Clinical Complications to Monitor

Serious complications occur more commonly in adults than children 1:

• Orchitis: Up to 38% of postpubertal males (sterility is rare) 1
• Aseptic meningitis: 4-6% of clinical cases 1
• Meningoencephalitis: Can cause permanent sequelae including paralysis, seizures, cranial nerve palsies 1
• Sensorineural deafness: May be sudden, bilateral, and permanent 1

Only 30-40% of mumps infections produce typical parotitis; 15-20% are asymptomatic and up to 50% present with nonspecific respiratory symptoms 1. This means serious complications can occur without parotid involvement.

Pregnancy Considerations

Mumps in first trimester increases risk of fetal death but is not associated with congenital malformations 1.

Endemic Circulation Pattern in Canada

Genotype G (Sheffield lineage) is the endemically circulating strain in Canada, detected in 96% of genotyped specimens from 2002-2020 5. This persistence despite high MMR vaccination coverage raises concerns about potential vaccine escape variants 5.